ABT logo

Abbott Laboratories (ABT)

$104.71

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ABT

Market cap

$181.35B

EPS

2.68

P/E ratio

32.2

Price to sales

3.7

Dividend yield

2.407%

Beta

0.544285

Price on ABT

Previous close

$107.45

Today's open

$106.50

Day's range

$104.59 - $108.18

52 week range

$81.97 - $132.03

Profile about ABT

CEO

Robert B. Ford

Employees

115000

Headquarters

Abbott Park, IL

Exchange

New York Stock Exchange

Shares outstanding

1.73B

Issue type

Common Stock

ABT industries and sectors

Healthcare

Medical Equipment & Supplies

News on ABT

Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026

ABT's EP business gains momentum as Volt adoption accelerates and new device launches expand its portfolio despite LAA market weakness.

news source

Zacks Investment Research • Nov 16, 2026

news preview

The Winners Inside SCHD - November 2026

The SCHD dividend ETF has extended its year-to-date lead over SPY to more than 20%, despite recent market volatility. October was SCHD's best month of 2026, with a nearly 10% gain; 43 holdings have returned more than twice SPY year-to-date. Twelve holdings announced dividend increases averaging 7.21%, alongside one special dividend; several delivered double-digit hikes.

news source

Seeking Alpha • Nov 17, 2026

news preview

Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?

ABT's strong Q3 results, broad-based segment growth and Nutrition spin-off plans support its outlook, despite softer 2026 sales guidance.

news source

Zacks Investment Research • Nov 13, 2026

news preview

Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business?

ABT's UltiSynq lead combines conduction system pacing and defibrillation, with strong clinical trial results supporting its potential to expand the company's cardiac rhythm management portfolio.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

news source

Zacks Investment Research • Nov 11, 2026

news preview

3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years

Hospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year.

news source

24/7 Wall Street • Nov 7, 2026

news preview

69 Dividend Champions Ranked By Quality Scores (November 2026)

I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued. Forty-nine have quality scores ≥ 7.0, indicating high quality. Top candidates by style: BRO and BMI for growth; BRO, BMI, and RGLD (below $262) for total return; CTBI for income; CAT for past performance.

news source

Seeking Alpha • Nov 7, 2026

news preview

3 Dividend Kings to Buy in November and Never Sell

AbbVie is an innovative pharmaceutical leader with an excellent long-term outlook. Abbott Laboratories has made business decisions that should help it overcome recent challenges.

news source

The Motley Fool • Nov 5, 2026

news preview

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Investment newsletters' favorite Dividend Aristocrat stocks

news source

Market Watch • Nov 4, 2026

news preview

Abbott Touts Favorable Outcomes In Cardiovascular Device Trials

Abbott Laboratories (NYSE:ABT) reported positive clinical trial results for two investigational cardiovascular devices at the Transcatheter Cardiovascular Therapeutics conference in San Diego, demonstrating high procedural success and low complication rates in patients with irregular heart rhythms and severely calcified coronary arteries.

news source

Benzinga • Nov 2, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Abbott Laboratories

Open an M1 investment account to buy and sell Abbott Laboratories commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ABT on M1